Health is key to every human life.As a Life Sciences executive, I've spent my career working to build better preventative measures for the sustained health of individuals and better outcomes for chronically ill patients by stewarding, building, leading, and advising companies with capital market transactions, strategic planning, complex restructurings, mergers and acquisitions, financial reporting, and process improvements.My passion and focus are centered around growing businesses with disruptive technologies through authentic leadership and strategic focus, alongside a foundation of data driven decision making and robust risk management and governance practices.✔️ Experienced in Investor Relations and Capital Markets ➡️ Strong public-company, capital markets and investor relations experience, with over $300M in financing transactions and 497% share price appreciation in the CFO role✔️Execution through Strategic Planning and Stakeholder Engagement ➡️ Led activities of strategic planning, budgeting, and FP&A processes, partnering with all levels of organization to create trust and accountability in annual operating plan and long-term strategic plan, ensuring adequate resources were in the hands of value creators within the business.✔️ Capturing Market Opportunity ➡️ Successfully transitioned from clinical-stage company to commercial organization, resulting in a compounded annual growth rate of 70%+, a high margin business with 90%+ SaaS gross margins and a device churn rate of <3%.✔️ Founded in Strong Financial Leadership ➡️ Secured numerous international grants, providing access to $10M+ in additional, non-dilutive cash funding.✔️ Effective Board Governance and Risk Management ➡️ Managed and developed relationships with auditors, tax advisors, remuneration consultants and lawyers, including the audit firm Ernst & Young, resulting in clean audits and reviews throughout tenure.📍To discuss how we might partner together, please contact me at T-Cruickshank@outlook.com.